Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of neuro-Behçet's disease

Clinical and Experimental Rheumatology

Volumn 27, Issue 2 SUPPL.53, 2009, Pages

  Hamzaoui, Kamel ^a   Maître, Bernard ^b   Hamzaoui, Agnès ^a,c  

^a UNIVERSITY OF TUNIS   (Tunisia)

^b CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^c ABDERRAHMAN MAMI HOSPITAL   (Tunisia)

Author keywords

Cerebrospinal fluid; Inflammatory sites; Matrix metalloproteinase; Neuro Beh et's disease

Indexed keywords

GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; BEHCET DISEASE; CELL COUNT; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DEMENTIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; STROKE;

ADULT; BEHCET SYNDROME; CASE-CONTROL STUDIES; FEMALE; HEADACHE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; YOUNG ADULT;

EID: 70350163036     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. AKMAN-DEMIR G, SERDAROGLU P, TASÇI B: Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. THE NEURO-BEHÇET STUDY GROUP. Brain 1999; 122: 2171-2182
2. HIROHATA S, ISSHI K, OGUCHI H et al.: Cerebrospinal fluid interleukin-6 in progressive neuro-Behçet's syndrome. Clin Immunol Immunopathol 1997; 82: 12-17 (Pubitemid 27049067)
3. LEPPERT D, LINDBERG RL, KAPPOS L, LEIB SL: Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Brain Res Rev 2001; 36: 249-257
4. SELLEBJERG F, SORENSEN TL: Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system. Brain Res Bull 2003; 61: 347-355 (Pubitemid 36952480)
5. CAMPBELL IL, PAGENSTECHER A: Matrix metalloproteinases and their inhibitors in the nervous system: the good, the bad and the enigmatic. Trends Neurosci 1999; 22: 285-287
6. YUSHCHENKO MM, MADER E, ELITOK A et al.: Interferon-beta-1b decreased matrixmetalloproteinase-9 serum levels in primary progressive multiple sclerosis. J. Neurol 2003; 250: 1224-1228
7. PAY S, ABBASOV T, ERDEM H et al.: Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation? Clin Exp Rheumatol 2007; 25 (Suppl. 45): S70-5.
8. INTERNATIONAL STUDY GROUP FOR BEHÇET'S DISEASE: Criteria for diagnosis of Behçet's disease. Lancet 1990; 355: 1078-1080
9. HENTATI F, FREDJ M, GHARBI N, HAMIDA M: Clinical and biological aspects of neuro-Behçet's in Tunisia. In: WECHSLER B, GODEAU P (Eds.) Behçet's disease. 1993 Amsterdam: Elsevier. p. 415-418
10. HOUMAN MH, NEFFATI H, BRAHAM A, HARZALLAH O, KHANFIR M, HAMZAOUI K: Behçet's disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients. Clin Exp Rheumatol 2007; 25: S58-64.
11. AL-ARAJI A, KIDD DP: Neuro-Behçet's disease: epidemiology, clinical characteristics, and management. Lancet Neurol 2009; 8: 192-204.
12. HEADACHE CLASSIFICATION SUBCOMMITTEE OF THE INTERNATIONAL HEADACHE SOCIETY: The international classification of headache disorders, second edition. Cephalgia 2004; 24: 1-160.
13. POSER CM, PATY DW, SCHEINBERG L et al.: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231
14. LEE KY, KIM EH, YANG WS et al.: Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis. J Neurol Sci 2004; 220: 73-78
15. LINDBERG RL, SORSA T, TERVAHARTIALA T et al.: Gelatinase B (matrix metalloproteinase (MMP)-9) and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children. Neuropathol Appl Neurobiol 2006; 32: 304-17.
16. SAKANE T, SUZUKI N, NAGAFUCHI H: Etiopathology of Behçet's disease: immunological aspects, Yonsei Med J 1997; 38: 350-358 (Pubitemid 128516394)
17. BENOIST C, MATHIS D: Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol 2001; 2: 797-801.
18. EGLIN RP, LEHNER T, SUBAK-SHARPE JH: Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behçet's syndrome and recurrent oral ulcers. Lancet 1982; ii 1356-1361
19. HAYASHI K, HOOPER LC, DETRICK B, HOOKS JJ: HSV immune complex (HSV-IgG: IC) and HSV-DNA elicit the production of angiogenic factor VEGF and MMP-9. Arch Virol 2009; 154; 219-226
20. DELCLAUX C, DELACOURT C, D'ORTHO MP, BOYER V, LAFUMA C, HARF C: Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 1996; 14: 288-295
21. SARUHAN-DIRESKENELI G, YENTÜR SP, AKMAN-DEMIR G, ISIK N, SERDAROǦLU P: Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol 2003; 145: 127-134
22. CHOI B, HWANG Y, KWON HJ et al.: Tumor necrosis factor alpha small interfering RNA decreases herpes simplex virus-induced inflammation in a mouse model. J Dermatol Sci 2008; 52: 87-97.
23. TURAN B, PFISTER K, DIENER PA et al.: Soluble tumour necrosis factor receptors sTNFR 1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's disease. Scand J Rheumatol 2008; 37: 135-141
24. BORHANI HAGHIGHI A, ITTEHADI H, NIKSERESHT AR et al.: CSF levels of cytokines in neuro-Behçet's disease. Clin Neurol Neurosurg 2009; 111: 503-511
25. ROBINSON SC, SCOTT KA, BALKWILL FR: Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha. Eur J Immunol 2002; 32: 404-412
26. SZABO K, ABLIN R, SINGH G: Matrix metalloproteinases and the immune response. Clin Appl Immunol Rev 2004; 4: 295-319.
27. KHUTH ST, AKAOKA H, PAGENSTECHER A et al.: Morbillivirus infection of the mouse central nervous system induces region-specific upregulation of MMPs and TIMPs correlated to inflammatory cytokine expression. J Virol 2001; 75: 8268-8282
28. TIAN W, KYRIAKIDES TR: Matrix metalloproteinase-9 deficiency leads to prolonged foreign body response in the brain associated with increased IL-1 beta levels and leakage of the blood-brain barrier. Matrix Biol 2009; 3: 148-159
29. HAMZAOUI K: Paradoxical high regulatory T cell activity in Behçet's disease.: Clin Exp Rheumatol 2007; 25 (Suppl. 45): S107-13.